A biotechnology company dedicated to furthering the development and commercialization of treatment systems for cancer and other diseases using focused heat energy in combination with other therapeutic devices or heat-activated genes.


Updates from The Motley Fool

Latest updates on Celsion from Fool.com.
A Fool Looks Back

This is the weekend that stateside BlackBerry (NASDAQ: BBRY) fans have been waiting for. The Z1...

The Fool Looks Ahead

There's never a dull week on Wall Street. Let's go over some of the news that will shape the week...

This Week in Biotech

With the SPDR S&P Biotech Index up 22% over the trailing-12-month period, it's evident that inv...

This Week in Biotech: Part 1

With the SPDR S&P Biotech Index up 28% over the trailing-12-month period, it's evident that inv...

New Hope for Celsion Investors?

Shares of biotech company Celsion (NASDAQ: CLSN) soared 10% in intraday trading after the compa...

3 Biotechs Burning Through Cash

Young, upstart pharmaceutical and biotech companies do one thing that almost no other industry do...



Stock Performance

View Interactive CLSN Charts
Sponsored by

Key Data Points

Primary metrics and data points about Celsion.
Current Price: $0.66
Prev Close: $0.66
Open: $0.66
Bid: $0.64
Ask: $0.70
Day's Range: $0.64 - $0.71
52wk Range: $0.62 - $2.05
Volume: 106,580
Avg Vol 123,037
Market Cap: $15M
P/E (ttm): -0.76
EPS (ttm): ($0.90)
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Celsion.
CAPS Rating 1 out of 5
 
78 Outperform
18 Underperform
CAPS All Stars
 
5 Outperform
9 Underperform

How do you think Celsion will perform against the market?



You pick for Celsion is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


Business Summary

Industry, sector and description for Celsion.

A biotechnology company dedicated to furthering the development and commercialization of treatment systems for cancer and other diseases using focused heat energy in combination with other therapeutic devices or heat-activated genes.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers